Table 11.
EPI schedule with RTS,S for areas on MVIP in Ghana
Age of administration | Vaccine | Mode of administration |
---|---|---|
At birth | BCG, OPV 0 | Intradermal, oral |
6 weeks | Penta 1, PCV 1, OPV 1, Rota 1, | Intramuscular, oral |
10 weeks | Penta 2, PCV 2, OPV 2, Rota 2 | Intramuscular, oral |
14 weeks | Penta 3, IPV, PCV 3, OPV 3 | Intramuscular, oral |
6 months | Vitamin A, RTS,S 1 | Oral, intramuscular |
7 months | RTS,S 2 | Intramuscular |
9 months | Measles-rubella (MR) 1, yellow fever, RTS,S 3 | Subcutaneous, intramuscular |
12 months | Vitamin A | Oral |
18 months | MR 2, Meningococcal ‘A’, Vitamin A | Subcutaneous, intramuscular, Oral |
24 months | RTS,S 4 | Intramuscular |
Source: GHS, 2019
Bolds indicate changes that have occurred in the EPI schedule of MVIP selected areas in Ghana as a result of the introduction of RTS,S